Latest US Food and Drug Administration Stories
Wearable technology to monitor a person’s health, the expanded use of minimally invasive heart repair procedures and eligibility recommendations for athletes with cardiovascular maladies top the American College of Cardiology’s (ACC) list of issues expected to be addressed in 2015.
WILMINGTON, Del., Dec. 19, 2014 /PRNewswire/ -- AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved LYNPARZA(TM) (olaparib) capsules.
PLANO, Texas, Nov. 19, 2014 /PRNewswire/ -- Argon Medical Devices, Inc.
DUBLIN, October 24, 2014 /PRNewswire/ -- - Increases Non GAAP diluted earnings per ADS growth guidance to the high thirty percent range for the full year (2014).
Experts team-up to help keep quality medicines available to those who need them TAMPA, Fla., Oct.
Key evaluation to inform the US Food and Drug Administration regulatory submission SYDNEY, Sept.
Pivotal Phase 3 Clinical Trial Targeted to Begin in First Half of 2015 PRINCETON, N.J., Sept. 17, 2014 /PRNewswire/ -- Soligenix, Inc.
Newly Acquired SGX301 Orphan Drug Candidate Being Evaluated for Treatment of Cutaneous T-Cell Lymphoma PRINCETON, N.J., Sept. 5, 2014 /PRNewswire/ -- Soligenix, Inc.
LISBON, Portugal, July 31, 2014 /PRNewswire/ -- Hovione today announced that its API plant in Cork, Ireland has successfully passed a pre-approval inspection by the US
DUBLIN, July 18, 2014 /PRNewswire/ -- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE
- A hairdresser.